Parkinson's News
Most Popular Parkinson's Story
Acadia inks $395 million development deal
Acadia Pharmaceuticals will pocket $30 million upfront and stands to earn another $365 million in milestones from Biovail as they pursue an approval for a late-stage drug designed to treat... Read more...
Latest Headlines
- October 15, 2009
- October 14, 2009
- September 1, 2009
- May 4, 2009
- August 26, 2008
- July 2, 2008
- April 11, 2008
- April 3, 2008
- January 31, 2008
- December 3, 2007
- August 22, 2007
- December 13, 2006
- December 7, 2006
- November 26, 2006
- October 25, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
